GE HealthCare wins FDA nod for CARESCAPE Canvas monitoring platform
FinkAvenue/iStock Editorial via Getty Images

GE HealthCare Technologies (NASDAQ:GEHC) announced Thursday that the FDA issued 510(k) clearance for its CARESCAPE Canvas patient monitoring platform, which offers individualized monitoring of patients.
The company says that CARESCAPE Canvas is compatible across GE HealthCareâs ecosystem, where current and prior versions of GE HealthCare devices are used to monitor about 100 million patients each year.

âThis new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,â Neal Sandy, general manager of monitoring solutions of GE HealthCare (GEHC), remarked.
GEHC, the healthcare spinoff of General Electric (GE), which made its public debut early this year, has already garnered five Buy-equivalent ratings on Wall Street, including those from Mizuho and Piper Sandler.

Read: Expecting the companyâs trading multiples to reach the levels of its peers, Seeking Alpha contributor GS Analytics issues a Buy rating on GEHC.